SHORT-TERM (1 WEEK) INGESTION OF WHEAT AMYLATE INHIBITOR IN OBESITY AND DIABETES

小麦淀粉酶抑制剂(WAI)将给6名肥胖者服用一周 6名糖尿病受试者测定WAI治疗糖尿病的近期疗效 碳水化合物代谢和胃肠功能。到目前为止，我们 已经将四名糖尿病患者加入了治疗方案。在这些患者中， 淀粉酶抑制剂似乎可以降低血糖水平。如果这些 研究完成后结果显著，我们可能会进行 一项更长期的研究。

Wheat Amylase Inhibitor (WAI) will be given for one week to 6 obese and 6 diabetic subjects to determine the short term effect of WAI on carbohydrate metabolism and gastrointestinal function. Thus far, we have entered four diabetics into the protocol. In these patients, the amylase inhibitor appears to reduce blood glucose levels. If these results are significant after completion of the study, we may undertake a much longer term study.